Clinical Trial Update: Cognitive Behavioral Therapy for Anxiety and Depression in COPD [Phase 2]

View source ↗

Summary

Phase 2 study evaluating cognitive behavioral therapy for anxiety and depressive symptoms in chronic obstructive pulmonary disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Chronic Obstructive Pulmonary Disease
• Depressive Disorders

Snippet

Sponsor: University of Bergen | Conditions: Anxiety, Depression | Phase 2 | Status: COMPLETED